Assessment of antihistamine use in early pregnancy and birth defects.

@article{Li2013AssessmentOA,
  title={Assessment of antihistamine use in early pregnancy and birth defects.},
  author={Qian Li and Allen A Mitchell and Martha M Werler and Wai-Ping Yau and Sonia Hern{\'a}ndez-D{\'i}az},
  journal={The journal of allergy and clinical immunology. In practice},
  year={2013},
  volume={1 6},
  pages={
          666-74.e1
        }
}
BACKGROUND Several studies have reported an association between use of specific antihistamines in early pregnancy and certain specific birth defects. OBJECTIVE To test 16 previously hypothesized associations between specific antihistamines and specific birth defects, and to identify possible new associations. METHODS We used 1998-2010 data from the Slone Epidemiology Center Birth Defects Study, a multicenter case-control surveillance program of birth defects in North America. Mothers were… CONTINUE READING
BETA

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 47 REFERENCES

FDANews release. FDAapprovesDiclegis for pregnant women experiencing nausea and vomiting

U. S. FoodandDrugAdministration
  • April 8,
  • 2013
VIEW 1 EXCERPT

Use of antihistamine medications during early pregnancy and isolated major malformations

B Kallen, PO Olausson
  • Birth Defects Res A Clin Mol Teratol
  • 2009

The safety of cetirizine during pregnancy. A prospective observational cohort study

C Weber-Schoendorfer, C. Schaefer
  • Reprod Toxicol
  • 2008
VIEW 1 EXCERPT